BHC vs SRPT · rev $5.38B vs rev $1.13B
Bausch Health Companies Inc (BHC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Bausch Health Companies Inc (BHC) is a drug manufacturers - specialty & generic company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BHC revenue for 2026-06-30 was $5.38B. Net income was -$1.17B. BHC currently screens at market cap $1.78B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
BHC currently screens at market cap $1.78B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BHC and SRPT stock pages for the full models.
Not investment advice.